AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Nov 12, 2015
29828_dirs_2015-11-12_3b2ad407-64ad-43d0-9ef0-f25b4a5da050.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-11-09
Reporting Person: MILLIGAN JOHN F (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-09 | Common Stock | M | 100000 | $14.5025 | Acquired | 1129108 | Direct |
| 2015-11-09 | Common Stock | S | 91491 | $107.5994 | Disposed | 1037617 | Direct |
| 2015-11-09 | Common Stock | S | 8509 | $108.2697 | Disposed | 1029108 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-09 | Non-Qualified Stock Option (right to buy) | $14.5025 | M | 100000 | Disposed | 2016-01-25 | Common Stock (100000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $107.11 to $108.11. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $108.13 to $108.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.